Use access key #2 to skip to page content.
$50.91 -0.03 (-0.06%)
5/16/2008 4:00 PM

LifeCell Corp (LIFC)

CAPS Rating:
****

The Company develops and markets tissue-based products for use in reconstructive, orthopedic and urogynecologic surgical procedures to repair soft tissue defects.

View All Commentary (LIFC)

Recs

0

Avatar boschen123 (< 20) Submitted: 4/24/08 11:50 AM : Outperform Start Price: $50.59 LIFC Score: -2.27

LifeCell Corp. is an industry leader in the field of regenerative tissues. They released a revolutionary new product (Strattice) in the first quarter of this year, as well as showing an increased product revenue of $54 million, up 27% from the same period last year. This is mainly because of their flagship product, Alloderm.

Report this Post Replies: 0 | Reply

Featured Broker Partners